Dabigatran etexilate for the treatment of acute venous thromboembolism in children (DIVERSITY): a randomised, controlled, open-label, phase 2b/3, non-inferiority trial - Halton, J; Brandão, LR; Luciani, M (Lancet Haematol, 2021)
et al.